Close Window
Aetna Aetna
Clinical Policy Bulletin:
Number: 0151


Aetna considers the use of hippotherapy (also known as equine therapy) experimental and investigational for the treatment of the following indications and all other indications because there is insufficient scientific data in the peer reviewed medical literature to support the effectiveness of hippotherapy for the treatment of individuals with these indications.

  • Autism
  • Behavioral and psychiatric disorders (including eating disorders)
  • Cerebral palsy or other motor dysfunctions (e.g., arthritis, balance deficits, head injury, multiple sclerosis, spinal cord injury, and stroke)


Cerebral palsy (CP) also known as static encephalopathy, refers to a wide variety of non-progressive brain disorders resulting from insults to the central nervous system during the perinatal period.  The management of the motor dysfunction of patients with CP includes the conventional orthopedic approach of range of motion, stretch, and strengthening, as well as neurodevelopmental treatment.  A general objective of physiotherapy for children with CP is to reduce the influence of abnormal muscle tone and facilitate the emergence of normal postural and movement components.  For many children with CP or other motor dysfunction, physical therapy is a long and arduous process.  In order to sustain patients' interest and enthusiasm in their continuing treatment, therapists have developed adjunctive therapeutic activities such as dancing, swimming, and horseback riding.

Hippotherapy, also known as therapeutic horseback riding, equine-facilitated therapy, or horse therapy, is the passive use of the physical movements of the horse in the treatment of patients with neurological or other disabilities.  This is often performed under the direct supervision of a physical therapist or occupational therapist who is horse-knowledgeable.  By using the horse as a treatment modality, the therapist tries to facilitate normal muscle tone and inhibit abnormal posture.  The therapist may place the patient in a variety of positions on the horse such as prone across horse, prone lengthwise with hips abducted and knees flexed, side sitting, or sitting.  It is believed that the rhythmic, swinging movement of the horse enhances balance, co-ordination, and motor development.  Patients who participate in therapeutic riding include not only children with CP, but also individuals with arthritis, multiple sclerosis, head injury, and stroke.  The horse is usually led at a walking or trotting pace by a skilled equestrian to ensure safety and expert handling of the animal.  Assistants are present, usually one on each side, to help repositioning or stabilizing the patient.  For more severely disabled patients, the therapist may also serve as a back rider.

For children with CP, hippotherapy utilizes the basic principles of Rood, Bobaths (individuals who had put forth/developed neurodevelopment treatment concepts for neuromuscular dysfunction), and proprioceptive neuromuscular facilitation.  It is believed that therapeutic horseback riding can reduce spasticity, maintain and increase range of motion in the upper extremities of these children.  Haskin and colleagues (1982) described the benefits of a hippotherapy program (30 mins per week) in a 5-year old patient who has participated in this type of therapy since she was 2 1/2.  Improvements included strengthening of the back and neck, better balance, ability to sit up longer, less spasticity in the lower extremities, the legs are externally rotated and abducted, and the feet are dorseflexed.  However, the patients also swam once a week and received physical therapy for her lower extremities 6 days a week.  Thus, it is unclear whether the observed improvements were due to hippotherapy, adjunctive therapeutic swimming, intensive physical therapy, and/or the result of natural growth and development.

Using a repeated-measured design, Bertoti (1988) assessed postural changes in 11 children (4 girls and 7 boys, aged 28 to 114 months) with spastic CP after participation in a 10-week hippotherapy program (1-hour session, 2 times per week).  Evaluation of posture was carried out 3 times by 3 pediatric physical therapists -- (i) pretest-1 followed by a 10-week period of no riding, (ii) pretest-2 followed by a 10-week therapeutic riding program, and (iii) post-test.  A composite score for each test period was computed for each patient, and a median score was calculated for the entire group at each test period.  A statistical difference was observed among the 3 test periods with significant improvement occurring during the period of hippotherapy.  Subjective clinical improvements such as reduced hypertonicity, as well as improved weight-bearing and functional balance skills were reported by parents and referring physical therapists.  These findings represented the first objective report that hippotherapy may have beneficial effect on the posture of children with spastic CP.  However, the author concluded that further investigation is needed to isolate additional variables such as range of motion, balance, weight shift, and strength, and to evaluate the effects of hippotherapy on different disabilities.

In an article on hippotherapy, Tuttle (1987) stated that research on the effect and application of the various forms of therapeutic horseback riding is needed to refine program planning, and to support funding and third party reimbursement.  Furthermore, a workshop on “The Health Benefits of Pets” sponsored by the National Institutes of Health concluded that “solid data on the success of therapeutic riding is limited. ... Future research is indicated to compare the efficacy of therapeutic riding with other clinical treatment procedures that do not involve the horse and to validate dramatic clinical observations” (NIH, 1983).  Additionally, in an article published in the Journal of American Veterinarian Medicine Association, Potter and colleagues (1994) stated that “Lack of scientific documentation of the benefits of therapeutic riding is a major obstacle that must be overcome. ... Research is critically needed in all aspects of therapeutic riding”.

In a single-subject experimental design study (n = 11), Hammer and associates (2005) examined whether therapeutic riding (TR, Sweden), also known as hippotherapy (HT, United States) may affect balance, gait, spasticity, functional strength, coordination, pain, self-rated level of muscle tension (SRLMT), activities of daily living (ADL), and health-related quality of life in patients with multiple sclerosis (MS).  The intervention comprised 10 weekly TR/HT sessions of 30 mins each.  The subjects were measured a maximum of 13 times.  Physical tests were: the Berg balance scale, taking a figure of 8, the timed up and go test, 10-m walking, the modified Ashworth scale, the Index of Muscle Function, the Birgitta Lindmark motor assessment, part B, and individual measurements.  Self-rated measures were: the visual analog scale (VAS) for pain, a scale for SRLMT, the Patient-Specific Functional Scale for ADL, and the Medical Outcomes Study 36-item Short-Form health survey (SF-36).  Data were analyzed visually, semi-statistically and considering clinical significance.  Results showed improvement for 10 subjects in one or more of the variables, particularly balance, and some improvements were also seen in pain, muscle tension, and ADL.  Changes in SF-36 were mostly positive, with an improvement in Role-Emotional seen in 8 patients.  These investigators concluded that balance and Role-Emotional were the variables most often improved, but TR/HT appeared to benefit the subjects differently.

Debuse et al (2005) noted that despite a substantial body of anecdotal and clinical evidence for its benefits, research evidence for hippotherapy is sparse.  In a questionnaire survey, these researchers explored the views of physiotherapists and people with CP who use hippotherapy.  This study was aimed to: (i) establish the pattern of hippotherapy practice in Germany and the U.K.; (ii) examine the perceived main effects of hippotherapy on people with CP in Germany and the U.K.; and (iii) investigate how these effects are being measured in both countries.  The results highlighted considerable differences in how hippotherapy is practiced in the U.K. compared with in Germany.  In spite of this, the study revealed agreement among respondents on the overall perceived effects of hippotherapy on individuals with CP, namely, the regulation of muscle tone, improvement of postural control and psychological benefits.  The results also indicated scant use of outcome measures to evaluate these effects.

Casady and Nichols-Larsen (2004) examined if hippotherapy has an effect on the general functional development of children with CP.  The study employed a repeated-measures design with 2 pre-tests and 2 post-tests conducted 10 weeks apart using the Pediatric Evaluation of Disability Inventory (PEDI) and the Gross Motor Function Measure (GMFM) as outcome measures.  A convenience sample of 10 children with CP participated whose ages were 2.3 to 6.8 years at baseline (mean +/- SD 4.1 +/- 1.7).  Subjects received hippotherapy once-weekly for 10 weeks between pre-test 2 and post-test 1.  Test scores on the GMFM and PEDI were compared before and after hippotherapy.  The authors concluded that results of this study suggest that hippotherapy has a positive effect on the functional motor performance of children with CP.  Hippotherapy appears to be a viable treatment strategy for therapists with experience and training in this form of treatment and a means of improving functional outcomes in children with CP, although specific functional skills were not investigated.

There are 2 main drawbacks with this study: (i) the GMFM scorers were not blinded to the order of test date and they were allowed to keep the scores sheets, which may have biased the scorers, and (ii) with the individualized approach to treatment, there is no protocol that would allow replication of this study.  The authors stated that hippotherapy has the potential to be a valuable treatment strategy in treating children with CP.  Future studies should use more homogeneous patient populations in terms of age and type of CP to ascertain precise areas of function affected most by hippotherapy.

In a review on the use of complementary and alternative therapies for the treatment of children with CP, Liptak (2005) noted that although studies of hippotherapy have shown beneficial effects on body structures and functioning, unanswered questions remain.  For example, it is unclear which subgroups of children with CP would benefit the most, what "dose" or frequency of intervention is optimal.

An assessment of the evidence for hippotherapy by the Institute for Clinical Effectiveness and Health Policy (Pichon Riviere et al, 2006) concluded: "The efficacy of this therapy does not seem to have been sufficiently proven for any specific indication.  Its recreational role and impact on the quality of life of these patients have not been sufficiently analyzed."

Snider et al (2007) performed a systematic review of the literature on hippotherapy as an intervention for children with CP.  Retrieved articles were rated for methodological quality using Physiotherapy Evidence Database (PEDro) scoring to assess the internal validity of randomized trials and the Newcastle Ottawa Quality Assessment Scale to assess cohort studies.  Population, Intervention, Comparison, and Outcomes (PICO) questioning was used to identify questions of interest to clinicians for outcomes within the context of the International Classification of Functioning, Disability and Health.  Levels of evidence were then accorded each PICO question.  The authors reported that there is Level 2a evidence that hippotherapy has short-term positive effects on muscle symmetry in the trunk and hip and that hippotherapy is effective for improving muscle tone in children with CP when compared with regular therapy or time on a waiting list.  However, no studies addressed participation outcomes.  (Note: Level 2a evidence refers to 1 or more "fair" quality randomized controlled trials [PEDro = 4 to 5]; 6 to 8 is considered "good"; and 9 to 10 is considered "excellent"). An assessment of this systematic evidence review by the Centre for Reviews and Dissemination (2009) found that this systematic review was "poorly reported" and that, "given the potential for error or bias during the review process, these cautious conclusions may not be reliable." In particular, the authors did not report how many reviewers carried out study selection and data extraction. Conclusions are limited due to heterogeneity of the primary data, small sample sizes, and limited generalization of the patient samples.

Hamill et al (2007) examined the effects of a once-weekly, 10-week hippotherapy program for 3 children, aged 27 to 54 months, with CP.  Participants were rated as Level V on the Gross Motor Function Classification System.  The Sitting Dimension of the Gross Motor Function Measure was used to establish a baseline of sitting abilities, and was administered every 2 weeks during intervention.  The Sitting Assessment Scale and the Gross Motor Function Measure were administered before, after, and 4 weeks post-intervention.  Parental perceptions of the hippotherapy intervention were assessed using questionnaires.  None of the children made gains on any of the standardized outcome measures.  However, parental perceptions were very positive, with reported improvements in range of motion and head control.

Lechner et al (2007) examined the effect of hippotherapy on spasticity and on mental well-being of persons with spinal cord injury (SCI), and compared it with the effects of other interventions.  A volunteer sample of 12 people with spastic SCI (American Spinal Injury Association grade A or B) were included in this study; interventions consisted of hippotherapy, sitting astride a Bobath roll, and sitting on a stool with rocking seat.  Each session lasted 25 mins and was conducted twice-weekly for 4 weeks; the control condition was spasticity measurement without intervention.  Main outcome measures were clinical rating by a blinded examiner of movement-provoked muscle resistance, using the Ashworth Scale; self-rating of spasticity by subjects on a VAS; and mental well-being evaluated with the self-rated well-being scale Befindlichkeits-Skala of von Zerssen.  Assessments were performed immediately after intervention sessions (short-term effect); data from the assessments were analyzed 3 to 4 days after the sessions to calculate the long-term effect.  By analyzing the clinically rated spasticity, only the effect of hippotherapy reached significance compared with the control condition (without intervention); median differences in the Ashworth scores' sum before and after hippotherapy sessions ranged between -8.0 and +0.5.  There was a significant difference between the spasticity-reducing effect of hippotherapy and the other 2 interventions in self-rated spasticity by VAS; median differences of the VAS before and after hippotherapy sessions ranged between -4.6 and +0.05cm.  There were no long-term effects on spasticity.  Immediate improvements in the subjects' mental well-being were detected only after hippotherapy (p = 0.048).  The authors concluded that hippotherapy is more efficient than sitting astride a Bobath roll or on a rocking seat in reducing spasticity temporarily.  Hippotherapy had a positive short-term effect on subjects' mental well-being.  The major drawbacks of this study was its small sample size and that hippotherapy had no long-term effects on spasticity.

Sterba (2007) reported on a review of evidence for hippotherapy in CP, and concluded that hippotherapy and horseback riding are effective in improving gross motor skills.  However, a critical assessment of this evidence review by the Centre for Reviews and Dissemination (CRD, 2008) stated that "given the methodological limitations of both included studies and the review, these conclusions should be treated with caution."  The CRD found insufficient information about the study selection, data extraction and quality assessment process to determine whether these had been carried out independently by more than one reviewer, "thus the possibility of bias cannot be ruled out."  The CRD stated that methodological limitations evident in the included studies were: the inclusion of participants with developmental disabilities other than cerebral palsy, lack of statistical analysis, small sample sizes, use of outcome measures which have not been proven reliable or valid, and the possibility of bias.  The CRD found that "study quality and study design do not appear to have been considered sufficiently when interpreting the results."

McGibbon and colleagues (2009) investigated the immediate effects of 10 mins of hippotherapy, compared with 10 mins of barrel-sitting, on symmetry of adductor muscle activity during walking in children with CP (phase I; n = 47).  These researchers also investigated the long-term effects of 12 weekly sessions of hippotherapy on adductor activity, gross motor function, and self-concept (phase II; n = 6).  Main outcomes measures were: for phases I and II -- adductor muscle activity measured by surface electromyography; for phase II -- gross motor function and self-perception profiles.  In the phase I study, hippotherapy significantly improved adductor muscle asymmetry (p < 0.001; d = 1.32).  Effects of barrel-sitting were not significant (p > 0.05; d = 0.10).  In the phase II study, after 12 weeks of hippotherapy, testing in several functional domains showed improvements over baseline that were sustained for 12 weeks post-treatment.  The authors concluded that hippotherapy can improve adductor muscle symmetry during walking and can also improve other functional motor skills.

McGee and Reese (2009) examined the immediate effects of a hippotherapy session on temporal and spatial gait parameters in children with spastic CP.  Subjects comprised 9 children with a diagnosis of CP (6 girls and 3 boys, 7 to 18 years of age).  Data for temporal and spatial gait parameters were collected immediately before and after a hippotherapy session.  No statistically significant differences (p < 0.05) were noted in the post-ride temporal and spatial gait parameter values when compared with the pre-ride values.  The authors concluded that the findings of this study provides baseline data for future research and useful clinical information for physical therapists using hippotherapy as a treatment modality for children with spastic CP.

Schwesig et al (2009) tested the hypothesis that hippotherapy has both positive short- and long-term effects on gait and posture control of persons suffering from motoric disabilities.  A total of 22 children and adolescents aged 9.69 +/- 4.01 years (range of 9.69 +/- 4.01 years) with motoric dysfunctions were included in a prospective matched-control study.  In each participant, gait and posture control were investigated on 4 different occasions (O1 to O4) using the Interactive balance system and the portable gait analysis sytem RehaWatch.  The dates of gait and posture analysis were defined as follows: O1: immediately prior to first therapeutic riding session (TRS); O2: immediately after first TRS; O3: after the last day of an 8-week period of daily TRS; O4: 7 weeks later after a TRS-free interval.  The following parameters were slightly improved (adjusted significance level of p < 0.003) after 8 weeks of therapeutic riding: (O1 versus O 3): (i) walking distance (p = 0.009, eta(2) = 0.339); (ii) pace frequency (p = 0.007, eta(2) = 0.358); (iii) walking speed (p = 0.006, eta(2) = 0.367), and (iv) time of attachment (p = 0.007, eta(2) = 0.360).  The only short-term effect observed was a significant decrease of the attachment phase (p = 0.002, eta(2) = 0.387).  Interestingly, gait symmetry remained unaffected.  Posturography (adjusted significance level of p < 0.01) at O1 versus O2 (short-term) showed a significant decrease of the performance of both the visual-nigrostriatal subsystem (p < 0.001) and the somato-sensory subsystem (p = 0.001).  At O1 versus O3 (long-term), the following parameters were sharply decreased: (i) postural stability (p = 0.011), and (ii) somato-sensory performance (p = 0.011).  The authors concluded that in the individuals investigated, an 8-week series of therapeutic riding did not improve posture control and had only a small positive effect on gait performance.  The reasons for these rather disappointing results could have been the low number of therapeutic riding sessions (0.5 sessions per week), and the relatively short duration (30 mins) of each session.  It remains to be seen, whether a higher density and longer duration of therapeutic riding sessions yields better results.

Oppenheim (2009) stated that there are no published studies specifically addressing complementary and alternative methods (CAM) in adults with CP.  However, national surveys of adults with chronic disabilities document that a majority of them use such treatments, that they are willing to pay out of pocket, if necessary, and that they believe that pursuing such treatment relieves pain, reduces stress and anxiety, and leads to improved feelings of fitness and well-being.  Individuals enjoy taking charge of their own health care decisions, and frequently feel more in control with these therapies than with more traditional methods.  In contrast to adults, there is some information on CAM in children with CP.  The author discussed some of the CAM used in children that may be carried over into adulthood, as well as the pitfalls for patients and conventional physicians as they try to sort out what might be helpful and what might be harmful in this arena.  Practitioners of both conventional and CAM therapies believe that exercise can be beneficial; accordingly, activities such as recreational sports, yoga, and hippotherapy may be continued from childhood into adulthood.  General treatments for stress and anxiety, through such activities as yoga and meditation, though not directed at CP per se, may be more popular for adults than children.  Research in this area should first identify what methods are being utilized and then subject these methods to well-designed outcome studies that take into account any associated risks.

Johnson (2009) analyzed evidence of the benefits of physical activity for youth with developmental disabilities.  A total of 3,263 citations was found.  Systematic reviews and articles about studies quantitatively examining the effects of physical activity in youth with developmental disabilities aged 0 to 20 years were included.  Only articles published in English in peer-reviewed journals were included; 3 systematic reviews and 14 studies were reviewed.  Strong evidence indicated that children and adolescents with developmental disabilities derive health benefits from participation in group exercise programs, treadmill training, or hippotherapy.  Lesser levels of evidence indicated that health benefits might be present for adapted skiing or aquatic programs.  Documented benefits of physical activity include improvements in aerobic capacity, improved gross motor function, and high levels of participant/parent satisfaction.  The author stated that further research studies are needed that are of greater scientific rigor including larger sample sizes, control groups, and stringent, replicable methodology.

More scientific evidence, especially controlled studies with outcome measures, is needed to ascertain the effectiveness of hippotherapy for the treatment of CP, MS, and other motor dysfunction.

In a pilot study, Shurtleff and Engsberg (2010) evaluated the effectiveness of hippotherapy in improving head/trunk stability in children with CP.  The participants were 6 children with spastic diplegia and 6 children without disability.  Head and trunk stability was challenged by using a motorized barrel and measured by a video motion capture system before and after a 12-week intervention of 45-min of hippotherapy a week.  The variables measured were anterior-posterior (AP) translation of the head, and spine at 5 points and average AP head angles.  At pre-testing, children with CP demonstrated significant differences in AP translation and AP head rotation compared with children without disability.  Following hippotherapy, children with CP demonstrated significant reductions in head rotation and AP translation at C7, eye, and vertex.  At post-testing, translation at C7 did not differ significantly between children with CP and children without disability.  After hippotherapy intervention, children with CP reduced their AP head rotation and translation, suggesting that they had increased stability of the head and trunk in response to perturbations at the pelvis.  The findings suggested that hippotherapy might improve head and trunk stability in children with CP.  These preliminary findings need to validated by well-designed studies with more subjects and follow-up.

Bronson et al (2010) reviewed the evidence for hippotherapy as an intervention to improve balance in persons with MS.  Major electronic databases were searched for articles relating to hippotherapy, MS and balance.  Only full length articles published in peer reviewed journals that were written in English or translated into English were included.  Articles were assessed using a modified quality index that was used for descriptive purposes only and did not exclude any study from the review.  All studies examined in this review were either case-control or case-series.  Collectively, all 3 studies reported improvements in balance.  Pre-test and post-test Berg Balance Scale scores in 2 studies revealed that primary progressive MS demonstrated the greatest amount of change after hippotherapy compared to other subtypes of MS.  The authors concluded that hippotherapy has a positive effect on balance in persons with MS and has an added benefit of enhancing quality of life.  They stated that data are limited and further research will lead to a greater knowledge base and has the potential to increase accessibility for hippotherapy to be used as a rehabilitation modality.

Munoz-Lasa et al (2011) examined the effect of THR on the balance and gait of ambulatory patients with MS.  A total of 27 subjects were included in the study.  Patients were divided into 2 groups:  (i) 12 underwent THR, and (ii) 15 traditional physiotherapy (for both groups, 2 series of 10 weekly sessions were performed).  Before and after the study period, the following outcome measures were applied: Extended Disability Status Scale (EDSS), Barthel Index, Tinetti Performance-Oriented Mobility Assessment (POMA).  In addition, patients of the THR group underwent a gait analysis to assess spatiotemporal gait parameters and ground reaction forces.  The THR group showed a significant improvement in POMA scores (p < 0.005) and 2 gait parameters: stride time (p < 0.04) and ground reaction forces (p < 0.01).  No statistically significant change was found in the control group.  The authors concluded that the results of the study showed that THR can improve balance and gait of ambulatory patients with MS.  Moreover, they stated that these findings are preliminary, but promising and in line with the recent literature.

In a meta-analysis, Zadnikar and Kastrin (2011) examined the effects of hippotherapy and therapeutic horseback riding (THR) on postural control or balance in children with CP.  To synthesize previous research findings, a systematic review and meta-analysis were undertaken.  Relevant studies were identified by systematic searches of multiple online databases from the inception of the database through to May 2010.  Studies were included if they fulfilled the following criteria: (i) quantitative study design, (ii) investigation of the effect of hippotherapy or THR on postural control or balance, and (iii) the study group comprised children and adults with CP.  The selected articles were rated for methodological quality.  The treatment effect was coded as a dichotomous outcome (positive effect or no effect) and quantified by odds ratio (OR).  The pooled treatment effect was calculated using a random-effects model.  Meta-regression of the effect size was performed against study co-variates, including study size, publication date, and methodological quality score.  From 77 identified studies, 10 met the inclusion criteria.  Two were excluded because they did not include a comparison group.  Therapy was found to be effective in 76 out of 84 children with CP included in the intervention groups.  The comparison groups comprised 89 children: 50 non-disabled and 39 with CP.  A positive effect was shown in 21 of the children with CP in the comparison group regardless of the activity undertaken (i.e., physiotherapy, occupational therapy, sitting on a barrel or in an artificial saddle).  The pooled effect size estimate was positive (OR 25.41, 95 % confidence interval [CI]: 4.35 to 148.53), demonstrating a statistically significant effectiveness of hippotherapy or THR in children with CP (p < 0.001).  Meta-regression of study characteristics revealed no study-specific factors.  The authors concluded that the 8 studies found that postural control and balance were improved during hippotherapy and THR.  They stated that although the generalization of their findings may be restricted by the relatively small sample size, the results demonstrated that riding therapy is indicated to improve postural control and balance in children with CP.

Whalen and Case-Smith (2012) examined the effectiveness of hippotherapy or THR on motor outcomes in children with CP.  Databases were searched for clinical trials of hippotherapy or THR for children with CP.  A total of 9 articles were included in this review.  Although the current level of evidence is weak, this synthesis found that children with spastic CP, Gross Motor Function Classification System (GMFCS) levels I to III, aged 4 years and above are likely to have significant improvements on gross motor function as a result of hippotherapy and THR.  Evidence indicated that 45-min sessions, administered once-weekly for 8 for 10 weeks, resulted in significant effects.  The authors concluded that the current literature on hippotherapy and THR is limited.  They stated that large randomized controlled trials (RCTs) using specified protocols are needed to more conclusively determine the effects on children with CP.  

Tseng et al (2013) evaluated the literature on the effectiveness of equine-assisted activities and therapies (EAAT) on gross motor outcomes representing the ICF component of body functions and activity in children with CP.  These investigators conducted a systematic review and meta-analysis of RCTs and observational studies of hippotherapy (HPOT) and THR for children with spastic CP.  Gross motor outcomes, assessed via muscle activity and muscle tone, gait, posture and GMFM were evaluated.  A total of 5 THR studies and 9 HPOT studies were included.  This meta-analysis indicated that short-term HPOT (total riding time 8 to 10 mins) significantly reduced asymmetrical activity of the hip adductor muscles.  HPOT could improve postural control in children with spastic CP, GMFCS level of less than 5.  However, the evidence did not show a statistically significant effect on GMFM after long-term HPOT or THR (total riding time, 8 to 22 hrs) in children with spastic CP.  The authors concluded that this systematic review found insufficient evidence to support the claim that long-term THR or HPOT provides a significant benefit to children with spastic CP.  They found no statistically significant evidence of either therapeutic effect or maintenance effects on the gross motor activity status in CP children.

Hippotherapy has also been used in the treatment of patients with autism.  However, there is a lack of reliable scientific evidence regarding its effectiveness.

In a pilot study, Manikowska (2013) examined the effect of hippotherapy on spatio-temporal parameters of gait in children with CP.  A total of 16 ambulatory CP children (GMFCS Level I to III; female: 10, male: 6; age of 5.7 to 17.5 years) qualified for hippotherapy were investigated.  Basic spatio-temporal parameters of gait, including walking speed, cadence, step length, stride length and the left-right symmetry, were collected using a 3-dimensional accelerometer device (DynaPort MiniMod) before and immediately after a hippotherapy session.  The Wilcoxon test was used to verify the differences between pre- and post-session results.  Changes of walking speed were statistically significant.  With the exception of step length, all spatio-temporal parameters improved, i.e., were closer to the respective reference ranges after the session.  However, these changes were not statistically significant.  The authors concluded that 1 session of hippotherapy may have a significant effect on the spatio-temporal parameters of gait in children with CP.  The findings of this small, pilot study need to be validated by well-designed studies.

In a single-blind RCT, Beinotti et al (2013) examined the impact of horseback riding therapy (HBRT) on the quality of life (QOL) of individuals with hemiparesis after stroke.  A total of 24 post-stroke patients were assigned to the experimental (n = 12) and control (n = 12) groups.  The control group participated in a conventional physiotherapy program, whereas the experimental group participated in physiotherapy plus HBRT sessions for 16 weeks.  The patients were evaluated by means of the SF-36.  Data analysis was applied through the use of descriptive and inferential statistics, with a 5 % level of significance.  Significant improvement was observed in the total score of the SF-36 in the experimental group when compared with the control group.  The combination of conventional physiotherapy and HBRT was associated with improvements in functional capacity (p = 0.02), physical aspects (p = 0.001), and mental health (p = 0.04) of the stroke patients.  The authors concluded that supplementation of conventional physiotherapy with HBRT, applied in different contexts, may yield positive QOL outcomes for people with stroke.  These investigators recommended that further studies be carried out to clarify the benefits of HBRT applied singly.

In a pilot study, Ajzenman et al (2013) examined if hippotherapy increased function and participation in children with autism spectrum disorder (ASD).  These researchers hypothesized improvements in motor control, which might increase adaptive behaviors and participation in daily activities.  A total of 6 children with ASD aged 5 to 12 participated in 12 weekly 45-min hippotherapy sessions.  Measures pre- and post-hippotherapy included the Vineland Adaptive Behavior Scales-II and the Child Activity Card Sort.  Motor control was measured pre-intervention and post-intervention using a video motion capture system and force plates.  Postural sway significantly decreased post-intervention. Significant increases were observed in overall adaptive behaviors (receptive communication and coping) and in participation in self-care, low-demand leisure, and social interactions.  The authors concluded that these results suggested that hippotherapy has a positive influence on children with ASD and can be a useful treatment tool for this population.  The findings of this small, pilot study need to be validated by well-designed studies.

O'Haire (2013) stated that the inclusion of animals in therapeutic activities, known as animal-assisted intervention (AAI), has been suggested as a treatment practice for ASD.  These investigators presented a systematic review of the empirical research on AAI for ASD.  A total of 14 studies published in peer-reviewed journals qualified for inclusion.  The presentation of AAI was highly variable across the studies.  Reported outcomes included improvements for multiple areas of functioning known to be impaired in ASD, namely increased social interaction and communication as well as decreased problem behaviors, autistic severity, and stress.  The author concluded that despite unanimously positive outcomes, most studies were limited by many methodological weaknesses; this review showed that there is preliminary "proof of concept" of AAI for ASD and high-lighted the need for further, more rigorous research.

Homnick et al (2013) examined the effect of an 8-week therapeutic riding (TR) program on measures of balance and QOL in community-dwelling older adults with established balance deficits.  The study was conducted at a Professional Association of Therapeutic Horsemanship (PATH) International Premier riding center.  Subjects comprised 9 adults (5 females, 4 males) with a mean age of 76.4 years (range of 71 to 83).  Treatment included an 8-week observation period followed by an 8-week TR program consisting of 1 hour/week of supervised horseback riding and an 8-week follow-up period.  Subjects received balance testing at weeks 0, 8, 16, and 24 using the Fullerton Advanced Balance Scale (FABS), and QOL was measured at weeks 8 and 16 using the Rand SF-36 QOL measure.  Outcome measures were change in the FABS and Rand SF-36.  There was no significant difference in balance scores between the start and end of the observation period.  There was a significant improvement in the balance score and perception of general health from the start to the end of the intervention period, and no significant difference between the end of the intervention and the end of study, suggesting that improvements may have been sustained.  The authors concluded that TR is a safe activity for older adults with mild-to-moderate balance deficits and leads to both improvements in balance and QOL.  Moreover, they stated that longer and larger studies are needed to ascertain the benefit of equine-assisted activities on improvements in balance and reduction in fall risk.

Dezutti (2013) noted that patients with eating disorders may have the most complex inter-disciplinary treatment plans of any mental illness.  Nurses need innovative evidence-based treatment interventions to assist their patients with eating disorders on their road to recovery.  Although much has been written about equine-assisted psychotherapy (EAP) and equine-facilitated psychotherapy, the literature has not described a detailed session that can help nurses understand how this experiential treatment works and the impact it can have on the patient.

CPT Codes / HCPCS Codes / ICD-9 Codes
HCPCS codes not covered for indications listed in the CPB:
S8940 Equestrian / hippotherapy, per session
ICD-9 codes not covered for indications listed in the CPB (not all-inclusive):
078.81 Epidemic vertigo
290.0 - 319 Mental disorders
307.1 Anorexia nervosa
307.50 - 307.59 Other and unspecified disorders of eating
332.0 Paralysis agitans
340 Multiple sclerosis
343.0 - 343.9 Infantile cerebral palsy
359.0 - 359.1 Muscular dystrophies and other myopathies
386.00 - 386.2 Vertiginous syndromes and other disorders of vestibular system
386.50 - 386.59 Labyrinthine dysfunction
430 - 438.9 Cerebrovascular disease
710.0 - 739.9 Diseases of the musculoskeletal system and connective tissue
780.4 Dizziness and giddiness Light-headedness; vertigo NOS
781.0 - 781.99 Symptoms involving nervous and musculoskeletal systems
783.40 - 783.43 Lack of normal physiological development in childhood
783.6 Polyphagia
784.60 Symbolic dysfunction, unspecified
784.69 Other symbolic dysfunction
800.00 - 804.99 Fracture of skull
806.0 - 806.9 Fracture of vertebral column with spinal cord injury
850.0 - 854.19 Intracranial injury, excluding those with skull fracture
905.0 Late effect of fracture of skull and face bones
907.0 Late effect of intracranial injury without mention of skull fracture
907.2 Late effect of spinal cord injury
952.0- 952.9 Spinal cord injury without evidence of spinal bone injury
959.01 Head injury, unspecified
V15.5 Other personal history of injury
V40.0 - V40.9 Mental and behavioral problems
V48.0 - V48.9 Problems with head, neck, and trunk

The above policy is based on the following references:
  1. Haskin M, Bream JA, Erdman WJ 2nd. The Pennsylvania horseback riding program for cerebral palsy. Am J Phys Med. 1982;61(3):141-144.
  2. Tuttle JI. The horse as member of a therapeutic team. Rehab Nursing. 1987;12(60):334-335.
  3. Bertoti DB. Effect of therapeutic horseback riding on posture in children with cerebral palsy. Phys Ther. 1988;68(10):1505-1512.
  4. National Institutes of Health (NIH), Office of Medical Applications of Research (OMAR). The health benefits of pets. OMAR Workshop, September 10-11, 1987. NIH Technology Assessment Statement 3. Bethesda, MD: NIH; 1987.
  5. Potter JT, Evans JW, Nolt BH Jr. Therapeutic horseback riding. J Am Vet Med Assoc. 1994;204(1):131-133.
  6. McGibbon NH, Andrade CK, Widener G, Cintas HL. Effect of an equine-movement therapy program on gait, energy expenditure, and motor function in children with spastic cerebral palsy: A pilot study. Dev Med Child Neurol. 1998;40(11):754-762.
  7. Benda W, McGibbon NH, Grant KL. Improvements in muscle symmetry in children with cerebral palsy after equine-assisted therapy (hippotherapy). J Altern Compl Med. 2003;9(6):817-825.
  8. Hammer A, Nilsagard Y, Forsberg A, et al. Evaluation of therapeutic riding (Sweden)/hippotherapy (United States). A single-subject experimental design study replicated in eleven patients with multiple sclerosis. Physiother Theory Pract. 2005;21(1):51-77.
  9. Debuse D, Chandler C, Gibb C. An exploration of German and British physiotherapists' views on the effects of hippotherapy and their measurement. Physiother Theory Pract. 2005;21(4):219-242.
  10. Casady RL, Nichols-Larsen DS. The effect of hippotherapy on ten children with cerebral palsy. Pediatr Phys Ther. 2004;16(3):165-172.
  11. Liptak GS. Complementary and alternative therapies for cerebral palsy. Ment Retard Dev Disabil Res Rev. 2005;11(2):156-163.
  12. Pichon Riviere A, Augustovski F, Alcaraz A, et al. Usefulness of hippotherapy [summary]. Report ITB No. 28. Buenos Aires, Argentina: Institute for Clinical Effectiveness and Health Policy (IECS); 2006.
  13. Snider L, Korner-Bitensky N, Kammann C, et al. Horseback riding as therapy for children with cerebral palsy: Is there evidence of its effectiveness? Phys Occup Ther Pediatr. 2007;27(2):5-23.
  14. Centre for Reviews and Dissemination (CRD). Horseback riding as therapy for children with cerebral palsy: Is there evidence of its effectiveness? Database of Abstracts of Reviews of Effectiveness (DARE). York, UK: University of York; 2009.
  15. Lechner HE, Kakebeeke TH, Hegemann D, Baumberger M. The effect of hippotherapy on spasticity and on mental well-being of persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88(10):1241-1248.
  16. Hamill D, Washington KA, White OR. The effect of hippotherapy on postural control in sitting for children with cerebral palsy. Phys Occup Ther Pediatr. 2007;27(4):23-42.
  17. Sterba JA. Does horseback riding therapy or therapist-directed hippotherapy rehabilitate children with cerebral palsy? Dev Med Child Neurol. 2007;49(1):68-73.
  18. Centre for Reviews and Dissemination (CRD). Does horseback riding therapy or therapist-directed hippotherapy rehabilitate children with cerebral palsy? Database of Abstracts of Reviews of Effectiveness (DARE). York, UK: University of York; 2008.
  19. McGibbon NH, Benda W, Duncan BR, Silkwood-Sherer D. Immediate and long-term effects of hippotherapy on symmetry of adductor muscle activity and functional ability in children with spastic cerebral palsy. Arch Phys Med Rehabil. 2009;90(6):966-974.
  20. McGee MC, Reese NB. Immediate effects of a hippotherapy session on gait parameters in children with spastic cerebral palsy. Pediatr Phys Ther. 2009;21(2):212-218.
  21. Oppenheim WL. Complementary and alternative methods in cerebral palsy. Dev Med Child Neurol. 2009;51 Suppl 4:122-129.
  22. Johnson CC. The benefits of physical activity for youth with developmental disabilities: A systematic review. Am J Health Promot. 2009;23(3):157-167.
  23. Shurtleff TL, Engsberg JR. Changes in trunk and head stability in children with cerebral palsy after hippotherapy: A pilot study. Phys Occup Ther Pediatr. 2010;30(2):150-163.
  24. Bronson C, Brewerton K, Ong J, et al. Does hippotherapy improve balance in persons with multiple sclerosis: A systematic review. Eur J Phys Rehabil Med. 2010;46(3):347-353.
  25. Zadnikar M, Kastrin A. Effects of hippotherapy and therapeutic horseback riding on postural control or balance in children with cerebral palsy: A meta-analysis. Dev Med Child Neurol. 2011;53(8):684-691.
  26. Munoz-Lasa S, Ferriero G, Valero R, et al. Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis. G Ital Med Lav Ergon. 2011;33(4):462-467.
  27. Whalen CN, Case-Smith J. Therapeutic effects of horseback riding therapy on gross motor function in children with cerebral palsy: A systematic review. Phys Occup Ther Pediatr. 2012;32(3):229-242.
  28. Tseng SH, Chen HC, Tam KW, et al. Systematic review and meta-analysis of the effect of equine assisted activities and therapies on gross motor outcome in children with cerebral palsy. Disabil Rehabil. 2013;35(2):89-99.
  29. Manikowska F, Jozwiak M, Idzior M, et al. The effect of a hippotherapy session on spatiotemporal parameters of gait in children with cerebral palsy - pilot study. Ortop Traumatol Rehabil. 2013;15(3):253-257.
  30. Beinotti F, Christofoletti G, Correia N, Borges G. Effects of horseback riding therapy on quality of life in patients post stroke. Top Stroke Rehabil. 2013;20(3):226-232.
  31. Ajzenman HF, Standeven JW, Shurtleff TL. Effect of hippotherapy on motor control, adaptive behaviors, and participation in children with autism spectrum disorder: A pilot study. Am J Occup Ther. 2013;67(6):653-663.
  32. O'Haire ME. Animal-assisted intervention for autism spectrum disorder: A systematic literature review. J Autism Dev Disord. 2013;43(7):1606-1622.
  33. Homnick DN, Henning KM, Swain CV, Homnick TD. Effect of therapeutic horseback riding on balance in community-dwelling older adults with balance deficits. J Altern Complement Med. 2013;19(7):622-626.
  34. Dezutti JE. Eating disorders and equine therapy: A nurse's perspective on connecting through the recovery process. J Psychosoc Nurs Ment Health Serv. 2013;51(9):24-31.

email this page   

Copyright Aetna Inc. All rights reserved. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.
Back to top